The New York Times recently published an article about genetic crop modification (“GMO“, as popularly known) by financial experts Mark Spitznagel and Nassim Taleb. Spitznagel and Taleb (yes, the “black swan” Taleb) think that tinkering with agricultural products by intentionally altering their genes through now-common scientific techniques is a formula for trouble. They feel that “complex chains of unpredictable changes in the ecosystem” could lead to catastrophe (shortages, high prices, economic depressions, starvation) if important crops get unexpectedly wiped out or are no longer able to grow in a changing environment.
To give their argument some weight, Taleb and Spitznagel compare the current GMO situation with the growth in the late 90’s and early 2000’s of hybrid financial arrangements for sub-prime investments (e.g. credit default swaps, tranched mortgage backed securities, collateralized debt obligations, etc). These investments were designed based on detailed economic studies, statistical analyses and complex mathematical and computer techniques, and became very popular in the big-money world of high-finance. Unfortunately, they had some unforeseen flaws in them, such that changing conditions in the US housing market triggered a cascade of events that ultimately led to a financial crisis and a “Great Recession”.
Their logic was criticized in an article in Forbes by Henry I. Miller, a biomedical scientist and former FDA drug regulator. Miller first points out that Spitznagel and Taleb are » continue reading …